Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T18:08:14.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.1 to v3.7.2 while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-17T17:55:15.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision label in the footer changed from v3.7.0 to v3.7.1; the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T18:58:40.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown, indicating access to the content is blocked. The page displays the site's header, footer, and navigation as part of the error screen.
    Difference
    18%
    Check dated 2026-09-19T20:25:51.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Footer Revision updated from v3.6.5 to v3.6.6, indicating a new page build; this is an administrative update applied to the page.
    Difference
    0.1%
    Check dated 2026-08-29T19:01:58.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5. This indicates a minor site maintenance update rather than a change to study content or data.
    Difference
    0.1%
    Check dated 2026-08-08T17:10:46.000Z thumbnail image

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.